NBD-557

For research use only. Not for therapeutic Use.

  • CAT Number: I003204
  • CAS Number: 333352-59-3
  • Molecular Formula: C17H24BrN3O2
  • Molecular Weight: 382.30
  • Purity: ≥95%
Inquiry Now

NBD-557(Cat No.:I003204)is a high-purity small-molecule compound used in HIV research. As a CD4 mimetic, it binds to the gp120 envelope glycoprotein of HIV-1, facilitating the study of viral entry mechanisms. Unlike NBD-556, NBD-557 is modified to enhance binding affinity and improve biological activity, making it a valuable tool for investigating the interaction between HIV-1 gp120 and host cell receptors. It is instrumental in developing therapeutic strategies targeting viral entry, aiding in the discovery of innovative approaches for HIV treatment.


Catalog Number I003204
CAS Number 333352-59-3
Synonyms

N/’-(4-bromophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide

Molecular Formula C17H24BrN3O2
Purity ≥95%
Target HIV
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name N'-(4-bromophenyl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)oxamide
InChI InChI=1S/C17H24BrN3O2/c1-16(2)9-13(10-17(3,4)21-16)20-15(23)14(22)19-12-7-5-11(18)6-8-12/h5-8,13,21H,9-10H2,1-4H3,(H,19,22)(H,20,23)
InChIKey QQRFLGRIDNNARB-UHFFFAOYSA-N
SMILES CC1(CC(CC(N1)(C)C)NC(=O)C(=O)NC2=CC=C(C=C2)Br)C
Reference

<p style=/line-height:25px/>
<br>[1]. Narumi, Tetsuo et al. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist. Bioorganic & Medicinal Chemistry Letters (2010), 20(19), 5853-5858.
<br>[2]. Sch?n A, Madani N, Klein JC, Hubicki A, Ng D, Yang X, Smith AB 3rd, Sodroski J, Freire E. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochemistry. 2006 Sep 12;45(36):10973-80.
<br>[3]. Singh IP, Chauthe SK. Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010. Expert Opin Ther Pat. 2011 Mar;21(3):399-416.
<br>[4]. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Identification of N-phenyl-N/’-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology. 2005 Sep 1;339(2):213-25.
</p>

Request a Quote